chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report has been received from a physician referring to two to three patients of unknown age or gender. The patients had not medical history, concurrent conditions, drug reactions/allergies or concomitant medications. On unknown dates, the patients were vaccinated with the first, the second and the third doses of ROTATEQ (strength, dose, route, lot # and expiration date were not reported) by oral route as rotavirus vaccination. Approximately in 2017 (reported as over last couple of months), the patients were diagnosed with rotavirus, after the patients had completed the 3 dose series of ROTATEQ. Stool samples were sent on an unspecified date to an unspecified laboratory, for confirmation of rotavirus and the results from the laboratory were positive for rotavirus. The patients were treated and subsequently, on unknown dates in 2017, they recovered from the event. No additional information was provided. The causal relationship between the event and the suspect therapy was not provided. Upon internal review the gastroenteritis rotavirus was considered as a medically significant event. Additional information has been requested.
I have no idea why your vaccine has temporarily stopped the clicking.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2, solution for injection), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "I have a ailment, rapid intermittent clicking in my right ear" (ongoing), notes: I have a ailment, rapid intermittent clicking in my right ear. As the vaccine wears down the clicking returns. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "I have no idea why your vaccine has temporarily stopped the clicking.".  Additional information: Description of Event Outcome: Hi, Just a thank you for an unexpected benefit from your Covid vaccine. I have a ailment, rapid intermittent clicking in my right ear. I have been to many Doctors seeking relief, but nothing worked. I have no idea why your vaccine has temporarily stopped the clicking. As the vaccine wears down the clicking returns. So it's not a cure, but the relief it provides is very welcoming. If you have any idea how this works I'd welcome the info.   Follow-up attempts are completed. No further information is expected.
A nurse reported that a 6 year old child received expired FLUMIST vaccine on 12/16/05. No adverse event was reported. The reporter causality is not provided to FLUMIST. No other information was provided.
Lightheaded, nausea, unable to breathe, tingling in hands 2 days after vaccine. Dr. could not find problems but pt still having symptoms.
Got the first shingles vaccine / got a horrible case of shingles; shingles pain / Drives me crazy sometimes; This case was reported by a consumer via media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. In December 2018, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles was unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional details were reported as follows : The age at vaccination was not reported. The patient received the first shingles vaccine and still got a horrible case of shingles in December 2018. At the time of reporting, the patient still dealing with shingles pain. The patient stated it drives the patient crazy sometimes and the patient was taking medications for it. No further information was reported.
Systemic: Dizziness / Lightheadness-Severe, Additional Details: vagal response - fainted
blister bump; redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (blister bump) and VACCINATION SITE ERYTHEMA (redness) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness). On 05-Feb-2021, the patient experienced VACCINATION SITE VESICLES (blister bump). At the time of the report, VACCINATION SITE VESICLES (blister bump) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. no treatment details reported.
Patient was given a pedi-dose and should have received at adult dose. Patient has not had any adverse reactions.
Patient mother reports that the evening of the vaccine, patient's leg became red, swollen and hot to the touch. As the evening progressed, his leg continued to swell with red streaks from the injection site down towards the ankle. Eventually the redness and swelling encompassed his entire thigh. At that point, the patient was taken to the ER. He was treated for cellulitis and anaphylaxis. He was given cephalexin and prednisone.
Patient cannot recall date of first Pfizer COVID 19 vaccine  Stated that second Pfizer COVID 19 Vaccine received 6/5/2021 On 6/6/2021 patient report unscheduled/irregular vaginal/uterine bleeding all day  On 6/7/2021 bleeding resolved spontaneously
pt recvd vax; on 2nov95 devel rash all over trunk & genital area;
About 12 hours after receiving my second dose, I woke up with an intense fever and chills. I then had shortness of breath and a rapid heart beat. I then went to the bathroom and fainted. I was still dizzy after my wife found me on the bathroom floor. The flu like symptoms remained for another 12 hours but I did not faint again. I also had a rash at the site of injection for many days.
This spontaneous report as received from a nurse refers to two patients of unknown age and gender. On 19-DEC-2013 the patients were vaccinated with a doses of PNEUMOVAX23 (lot # J010396, exp.date: 16-FEB-2015) (reported as 06-FEB-2015), 0.5 ml, intramuscularly), that were opened and left at 70F for 5 hours. No adverse reactions were reported. Additional information has been requested.
Began with fussiness, inconsolable, vomiting at 7pm q 20 mins; called our night answering service at 2:28am; bright red watery stools as well; seen at ER ~ 3am.
pt recvd vax 19AUG92; 27AGU92 MOC noticed that pt had a fine red rash which was located primarily on the trunk, arms, legs; rash was pruritic & appeared to be flat just under the skin; t99;
Fever greater than 102.5, chills, dizziness, aches, pains in thoracic area, nausea. Was going to emergency department to seek treatment today.
Patient reported nausea and left arm feeling heavy approximately 2 - 3 minutes after receiving COVID vaccination.
discouragement; diarrhea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DISCOURAGEMENT (discouragement), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 940875) for COVID-19 vaccination.     Concomitant products included AMOXICILLIN SODIUM (AMOXILLIN [AMOXICILLIN SODIUM]) for an unknown indication.    On 27-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Nov-2021, the patient experienced DISCOURAGEMENT (discouragement), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills). On 01-Dec-2021, DISCOURAGEMENT (discouragement), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided.
A 12+ year dose was given to an 11 year old patient. Mistake was caught about 1 hour after injection. Physician was immediately notified; supervising physician with no concerns for patient receiving higher dose since she is an adult weight and almost 12 years old. Mother of Child was also notified after physician. No know adverse effects from vaccine at this time.
Starting 7/1/2021, my stomach started hurting and I started throwing up. I called an ambulance and went to the ER. I was diagnosed with bowel obstruction. I was treated and discharged. Then 3 days later on 7/3/2021, I was feeling very weak and not getting better. I had left side droopy eyes and mouth. I was taken back to the hospital and initially they thought I was having a stroke. They ran a bunch of tests and I was not having a stroke. I was in the hospital for 3 days then discharged to a rehab center where I was finally diagnosed with Bell's Palsy.
With in my arm got soar. About four hours later I started getting a head ache and feeling cold, I couldn't get warm, I felt very tired. About the next thirty hours I had body ache and head ache my arm got very heavy and hurt, I did not run a fever but felt very restless and achy. I was very tired and didn't work the following day, didn't have much of an appetite. I had some mild itching on my arm.
Approximately 1 hour after injection, site became ache, swelling, hot, and patient had migraine. Pt took BENADRYL. Arm swollen from back of down to elbow for several days. Swelling is coming down per patient.
develop eczema and It still had not gone away; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (develop eczema and It still had not gone away) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A20A, 039K20A and 059E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ECZEMA (develop eczema and It still had not gone away). The patient was treated with LOSARTAN for Eczema, at a dose of 50 mg and LISINOPRIL for Eczema, at an unspecified dose and frequency. At the time of the report, ECZEMA (develop eczema and It still had not gone away) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Allergy test: results not provided Results not provided.         No concomitant information was reported. Patient's weight provided was 160.  Patient stated that after the second shot, he started to develop eczema and hence visited the dermatologist and they did strip testing for allergies and couple injections for a steroid. Patient stated that the eczema has still not reduced and queried whether it was a normal effect. He disclosed that the doctor changed lisinopril to losartan 50mg in hopes that the eczema would reduce, but it did not.
This spontaneous report as received from a medical assistant refers to a 18 months old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 23-JUN-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2014) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. Addtional information has been requested.
Grade 2 fatigue; Grade 2 fever with a temperature of 102.5; Grade 2 myalgia; Grade 1 chills; Grade 1 conjunctivitis; Grade 1 edema limbs; Grade 1 injection site reaction; Grade 1 headache; This is a spontaneous report from a contactable physician, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 20Apr2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 30Mar2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 20:00, approximately 10 hours after receiving the second dose of the Pfizer covid vaccine, the patient developed the following symptoms: Grade 2 fatigue, Grade 2 fever with a temperature of 102.5, Grade 2 myalgia, Grade 1 chills, Grade 1 conjunctivitis, Grade 1 edema limbs, Grade 1 injection site reaction and Grade 1 headache. On 20Apr2021 at 20:00, the patient underwent body temperature and the result was 102.5 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events Grade 2 fever with a temperature of 102.5 and Grade 1 chills was recovered on an unknown date in Apr2021. The clinical outcome of the events Grade 2 fatigue, Grade 2 myalgia, Grade 1 conjunctivitis, Grade 1 edema limbs, Grade 1 injection site reaction and Grade 1 headache was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Chest hurting; Breathing becomes painful; Tingling sensation on her tongue and says that it feels bigger than normal; Tingling sensation on her tongue and says that it feels bigger than normal; Feeling cold; A spontaneous report was received from a healthcare professional concerning a 23-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chest hurting, breathing became painful, tingling tongue, tongue discomfort, feeling cold.   The patient's medical history was not provided.  No concomitant medications were provided.  On 09 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot Number: 012L20A) for prophylaxis of COVID-19 infection.   On 09 Jan 2021, the patient experienced a tingling sensation on her tongue and felt that it was bigger than normal.  She was given Diphenhydramine as an intervention.  The patient started to feel cold.  After 20 minutes, breathing became painful and her chest was hurting.  The patient was given epinephrine and was transported to the hospital for continued monitoring.    Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, chest hurting, breathing became painful, tingling tongue, tongue discomfort, feeling cold, was considered were not recovered/resolved.; Reporter's Comments: This case concerns a 23-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot 012L20A), and who experienced the serious unlisted events of Chest pain and Painful respiration and the non-serious unlisted events of tingling tongue, tongue discomfort, and feeling cold.  Patient was treated with Benadryl and EpiPen prior to being transferred to hospital.  Based on the current available information and temporal association between vaccination and the onset of events on the day of vaccination, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
Breakthrough case of COVID-19: I took cold medicine for a few weeks, it was too late to receive antiviral medication. I had a tele visit with the doctor and took a PCR test and tested positive.
May 11, 2010 received immunization for college in right arm. I noticed lump on right side of my neck above my collar bone. Redness, itching, hard skin, tiny bumps on the injection site. I noticed these symptoms on 05/16/2010. The itching and redness is unusual. I don't scratch that spot though I want to. I don't want to infect it. I called doctor and reported symptoms approximately 9:00am on Monday, May 17, 2010. The nurse scheduled an appointment for me to come in. I scheduled for Tuesday, May 18, 2010 at 5:30pm so that this would not affect my work.
patient called the office one day after vaccine reporting watery eyes, cough, lip swelling, mild dyspnea and no arm pain or swelling at the inj. site.  Patient took benadryl and medrol dose pack and reported much improvement.
pt recv vax;rxn on 27feb96 in the eve,fussy & generalize rash;
Pain at injection site, followed by stiffness at site, decreased ROM, worsening pain, now with tingling in arm.
moderate myalgias; arthralgias; headaches; rhinorrhea; chest tightness; scratchy throat; This is a spontaneous report from a contactable physician (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration in Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the 1st dose of the Pfizer COVID19 vaccine this week. In Dec2020, patient had 3 days of moderate myalgias, arthralgias, and headaches. Patient also experienced rhinorrhea, chest tightness, and scratchy throat (Dec2020), which were reportedly not effects associated with the vaccine. Patient did get a post vaccination COVID test (PCR) in Dec2020 because of these symptoms, which was negative. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the available information, a contributory role of vaccination with BNT162B2 in the development of the reported events cannot be excluded.
Patient experienced an itchy COVID arm rash (5- 6 inches)  24hours after vaccination. She experienced chills. She went to bed and by following night symptoms left.  Rash is still present. Rash is painful to touch but no itch. Patient did take benadryl, Emergen-C and tylenol
Extremely tired/ Weary; Raging rash all over his body, shoulder, back, elbow, knees, groin, butt, Itching his body when sitting; This spontaneous case was reported by a patient family member or friend and describes the occurrence of RASH PRURITIC (Raging rash all over his body, shoulder, back, elbow, knees, groin, butt, Itching his body when sitting) and FATIGUE (Extremely tired/ Weary) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included DOFETILIDE, METOPROLOL, ACETYLSALICYLIC ACID (BABY ASPIRIN), SITAGLIPTIN PHOSPHATE (JANUVIA), CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]), FINASTERIDE, TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), WARFARIN, GUAIFENESIN (MUCINEX), HYDROCODONE, LORATADINE and INSULIN GLARGINE (LANTUS) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH PRURITIC (Raging rash all over his body, shoulder, back, elbow, knees, groin, butt, Itching his body when sitting). On an unknown date, the patient experienced FATIGUE (Extremely tired/ Weary). At the time of the report, RASH PRURITIC (Raging rash all over his body, shoulder, back, elbow, knees, groin, butt, Itching his body when sitting) had not resolved and FATIGUE (Extremely tired/ Weary) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 10-Feb-2021 patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) (batch no.  013M20A) for COVID-19 vaccination. On 02-Nov-2021 patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) on left nondominant deltoid (batch no. 039F21A) for COVID-19 vaccination.  A week after the first shot, the patient got a raging rash all over his body, rash was on the shoulders, back, elbow, knees, groin, and butt and went to several dermatologist and gave him shots of steroids and put him on more steroids (unspecified) and more itch cream (unspecified). It never went away, and the rash was still there. The steroid shot helped it a bit but as soon as he got off of the steroid shots, the rash came back. He sits and itches his body and he was extremely tired and it is wearing him out. He was able to sleep but then wakes up in the middle of the night, it drives him crazy. An allergist was going to do a skin prick test on him, and already gave him another large injection of steroids.
Fatigue set in about 10 pm 3/13/2021. Went to sleep. Woke up 3/14/2021, 12:41pm. Spent the day tired.
-15 minutes after: legs felt heavy  -30 minutes after: bilateral lower extremity numbness and tingling. At this point, went to urgent care. Was told that symptoms should go away in 1-2 days and was sent home without treatment. -1 day after: numbness and tingling disappeared, developed BLE weakness. Still able to walk, but difficulty going up/down stairs and sitting/standing. Unable to walk at normal pace. Walking more than an hour a day causes moderate pain. Seen by PCP, labs drawn (CMP, CBC, ESR/CRP, vit B12, thyroid, HIV, syphilis), labs normal. Pending neurology consult.  Almost 3 weeks post-vaccine (1/13/2021), symptoms have not improved. Still experiencing difficulty walking for prolonged periods of time and still unable to walk at a normal pace without pain.
Client received first Pfizer COVID shot at 0835.  Left arm began itching, throat got scratchy, voice was raspy, and was scratching neck at 0840.  She took a 25mg Bendryl gelcap from her purse and notified RN.  Vitals at 0840 were 146/84, P 80 O2 100%. At  0845,  not improving.  Administered additional 25 mg Beandryl IM to left deltoid.  Vitals at 0850 were 148/82, P 75, O2 98%.  0855, itching had decreased, voice no longer raspy and stated she felt better.  0905, left HD by POV with daughter driving.  Instructed to lay down when she got home d/t Benadryl.  Followed up w/client at 1410 pm.  Was feeling much better.  All sx were gone and no new sx had developed
Patient is 12 y/o and received the 5-11 year old dose of the vaccine. No adverse reaction was observed during observation period. Parent was informed by provider. Patient  scheduled 2nd dose for 12+ formulation. in office clinic.
Hives outbreak, all over the entire body, constant, does not respond to generation 1 or 2 H1 antihistamines or H2 antihistamines. Partially effective with prednisone 20 mg  once in the morning, hives will start coming back at night
headache, fever, ad confusion since getting vaccine; worsening generalized weakness over the next 2-3 days causing inability to perform ADLs or ambulate
nausea, bodyaches, headache, 100.7 degree fever, and chills. side effects started on saturday 10/30/21 at 4:00 am and lasted until 5:00 pm that day. alternating between ibuprofen and acetaminophen helped to slightly relieve side effects.